JY
NYMX

Jeff Yass’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Jeff Yass’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,100
Closed -$40K – 11918
2020
Q3 		$40K Sell
16,100
-45,800
-74% -$133K ﹤0.01% 10261
2020
Q2 		$220K Buy
+61,900
New +$196K ﹤0.01% 8876
2019
Q4 		– Sell
-12,500
Closed -$23K – 10905
2019
Q3 		$23K Sell
12,500
-5,000
-29% -$8.74K ﹤0.01% 9936
2019
Q2 		$25K Buy
+17,500
New +$30.6K ﹤0.01% 9980
2019
Q1 		– Sell
-15,400
Closed -$20K – 10122
2018
Q4 		$20K Buy
+15,400
New +$28.2K ﹤0.01% 8680
2018
Q3 		– Sell
-45,600
Closed -$153K – 10515
2018
Q2 		$153K Buy
45,600
+15,700
+53% +$60.3K ﹤0.01% 8825
2018
Q1 		$126K Buy
+29,900
New +$104K ﹤0.01% 8608
2017
Q3 		– Sell
-34,100
Closed -$150K – 9850
2017
Q2 		$150K Sell
34,100
-21,400
-39% -$87.9K ﹤0.01% 8495
2017
Q1 		$201K Sell
55,500
-45,400
-45% -$149K ﹤0.01% 7999
2016
Q4 		$269K Buy
100,900
+27,500
+37% +$85.3K ﹤0.01% 8170
2016
Q3 		$239K Buy
73,400
+47,300
+181% +$155K ﹤0.01% 7307
2016
Q2 		$87K Buy
+26,100
New +$64.1K ﹤0.01% 8086
2014
Q4 		– Sell
-90,400
Closed -$393K – 10222
2014
Q3 		$393K Buy
90,400
+52,700
+140% +$258K ﹤0.01% 7621
2014
Q2 		$187K Sell
37,700
-2,700
-7% -$13.9K ﹤0.01% 9120
2014
Q1 		$221K Buy
+40,400
New +$234K ﹤0.01% 8086

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Jeff Yass's NYMX Position: Q3 2023 in Review

Jeff Yass sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 41,914 shares — an estimated $7.96K sold.

Jeff Yass first reported a position in NYMX in Q2 2013 and held it in 38 quarters. The position peaked at $780K in Q1 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Jeff Yass reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Jeff Yass sold 41,914 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $7.96K.
  • Jeff Yass first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 38 quarters.
  • Jeff Yass's Nymox Pharmaceutical Corp position peaked at $780K in Q1 2020.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.